Venous thromboembolism (VTE) is a common diagnosis for many hospitalized, medically ill, non-surgical patients. VTE is a serious concern in that it is associated with significant morbidity and mortality.1 A VTE diagnosis is particularly significant for patients because the risk of recurrence is great, and patients require adequate monitoring and management. There has been a substantial paradigm shift from a time when almost all medically ill patients received prophylaxis to current guidelines recommending a tailored approach according to risk stratification guidance.
SHM has developed a compendium, supplemental suite of resources, and educational modules to review evidence-based strategies for appropriately selecting which VTE patients require prophylaxis as well as identifying appropriate candidates for extended prophylaxis.
Learning Materials include:
- Compendium discussing VTE risk stratification frameworks and practice, VTE prophylactic options for the hospitalized, medically ill patient and considerations for post-discharge prophylaxis, and strategies for thromboembolic prevention in COVID-19 patients
- Recorded Webinar Modules:
- Risk Stratification, Guidance for Prophylaxis
- In-Hospital VTE Prophylaxis
- Post-Discharge VTE Prophylaxis
- COVID-19 and Thrombosis
- Sample VTE Prophylaxis Order Set Specifications
- Eligibility Checklist for Post-Discharge VTE Prophylaxis
- Risk Assessment Models
- Patient Educational Video